APA (7th ed.) Citation

LK, H., J, M., M, A., JS, L., & S, D. (2026). Cutaneous Adverse Effects of Hormonal and HER2-Targeted Therapies in Breast Cancer Patients: A Case Series. Journal of drugs in dermatology : JDD, 25(7), 659. https://doi.org/10.36849/JDD.9458

Chicago Style (17th ed.) Citation

LK, Huggins, Manjunath J, Alorainy M, Leventhal JS, and Deverapalli S. "Cutaneous Adverse Effects of Hormonal and HER2-Targeted Therapies in Breast Cancer Patients: A Case Series." Journal of Drugs in Dermatology : JDD 25, no. 7 (2026): 659. https://doi.org/10.36849/JDD.9458.

MLA (9th ed.) Citation

LK, Huggins, et al. "Cutaneous Adverse Effects of Hormonal and HER2-Targeted Therapies in Breast Cancer Patients: A Case Series." Journal of Drugs in Dermatology : JDD, vol. 25, no. 7, 2026, p. 659, https://doi.org/10.36849/JDD.9458.